Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vitamin E supplementation and cataract: randomized controlled trial.

John J McNeil1, Luba Robman, Gabriella Tikellis

  • 1Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia. john.mcneil@med.monash.edu.au

Ophthalmology
|January 9, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toxoplasmosis meets the World Health Organization criteria for a neglected tropical disease.

PLoS neglected tropical diseases·2026
Same author

Who CaREs - We do: Development of a community and researcher engagement program in translational medicine.

Research involvement and engagement·2026
Same author

Diabetic retinopathy screening in Australian general practice: persistently low uptake despite national guidelines and equity initiatives.

Journal of diabetes and metabolic disorders·2025
Same author

Addressing the inequities in interstitial lung disease care outside specialised centres in Australia.

Respiratory medicine and research·2025
Same author

Top 10 research priorities for pulmonary fibrosis in Australia: an update.

Thorax·2025
Same author

Patient and healthcare professional perspectives on telehealth in the care of interstitial lung disease.

Chronic respiratory disease·2025
Same journal

Metastasis of Nasopharyngeal Squamous Cell Carcinoma to the Angle.

Ophthalmology·2026
Same journal

Endocrine Mucin-Producing Sweat Gland Carcinoma of Eyelid.

Ophthalmology·2026
Same journal

Multimodal Imaging of Optic Nerve Invasion in Unilateral Retinoblastoma.

Ophthalmology·2026
Same journal

Avacincaptad Pegol Slows Progressive Ellipsoid Zone Degradation/Loss in Eyes With Geographic Atrophy.

Ophthalmology·2026
Same journal

Access to Intravitreal Anti-VEGF Drugs in Persons with Medicare Advantage Compared with Medicare Fee-For-Service.

Ophthalmology·2026
Same journal

Re: Dones et al.: Emergency department use of ocular point-of-care ultrasound and its utility in diagnosis at a tertiary academic medical center (Ophthalmology. 2026;133:720-727).

Ophthalmology·2026
See all related articles

Daily vitamin E supplementation did not reduce the incidence or progression of age-related cataracts in a 4-year clinical trial. These findings suggest vitamin E is not effective for preventing or slowing cataract development.

Area of Science:

  • Ophthalmology
  • Nutritional Science
  • Clinical Trials

Background:

  • Age-related cataracts are a leading cause of vision impairment.
  • Antioxidants, such as vitamin E, have been investigated for their potential role in preventing or slowing cataract progression.

Purpose of the Study:

  • To evaluate the efficacy of daily vitamin E supplementation (500 IU) in reducing the incidence and progression of age-related cataracts.

Main Methods:

  • A prospective, randomized, double-masked, placebo-controlled trial involving 1193 participants aged 55-80 with early or no cataracts.
  • Participants received either 500 IU of vitamin E or a placebo daily for 4 years.
  • Cataract incidence and progression were assessed annually using clinical grading and digital imaging analysis.

Related Experiment Videos

Main Results:

  • No significant difference was observed in the 4-year cumulative incidence rates for cortical, nuclear, or posterior subcapsular cataracts between the vitamin E and placebo groups.
  • Vitamin E supplementation did not significantly affect the progression rates of any type of age-related cataract.
  • Rates of cataract extraction and lens changes were similar in both treatment groups.

Conclusions:

  • Daily intake of 500 IU of vitamin E for 4 years did not demonstrate a benefit in preventing or slowing the progression of age-related cataracts.
  • The study findings do not support the use of vitamin E for the prevention or management of age-related cataracts.